Daron Evans, President and CEO at NEPHROS INC (NEPH), bought 4,069 shares at $0.32 ($1K) on 2016-12-07, disclosed to the SEC on 2016-12-09.
Open-market purchase of $1k NEPH by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| RZLT | BUY | 2025-06-24 | $20K | — | Filing → |
| RZLT | BUY | 2025-03-28 | $58K | — | Filing → |
| RZLT | BUY | 2024-12-18 | $43K | — | Filing → |